Since 1999, Inotek’s scientists and physicians have been working to harness the cytoprotective properties of adenosine. Today, our most advanced drug candidate, trabodenoson, is a highly selective adenosine mimetic that has been shown to reduce intraocular pressure in patients with ocular hypertension and open-angle glaucoma, by enhancing the eye’s natural pressure-regulating system.
Company Details
- Employees
- 7
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.inotekpharma.com/
Inotek Pharmaceuticals Co Questions
Inotek Pharmaceuticals Co's website is http://www.inotekpharma.com/
Inotek Pharmaceuticals Co's LinkedIn profile is https://www.linkedin.com/company/inotek-pharmaceuticals-co
Inotek Pharmaceuticals Co has
7 employees.
View email and phone details for 7
employees at Inotek Pharmaceuticals Co.
Inotek Pharmaceuticals Co's industry is
Pharmaceutical Manufacturing
Inotek Pharmaceuticals Co's top competitors are
Cellceutix Corporation,
Kiniksa Pharmaceuticals,
Ancora Pharmaceuticals,
Cardurion Pharmaceuticals,
Medikunion,
Boulos & Cooper Pharmaceuticals,
Inotek Technologies Pvt Ltd,
Parexel,
Innothera,
Rocket Pharmaceuticals.
Inotek Pharmaceuticals Co's categories are Pharmaceutical Manufacturing
